Ryvu Therapeutics logo

Ryvu Therapeutics Employee Directory

Biotechnology ResearchLesser Poland, Poland201-500 Employees

Ryvu Therapeutics is a clinical-stage biotechnology company focused on discovering and developing novel small molecule therapies for cancer. Its internally discovered pipeline explores diverse mechanisms informed by cancer biology, including kinase inhibition, synthetic lethality, and immuno-oncology approaches. Its lead programs include RVU120, a selective CDK8/CDK19 inhibitor in early clinical development for hematologic malignancies and solid tumors, and SEL24 (MEN1703), a dual PIM/FLT3 inhibitor licensed to Menarini currently in Phase II for AML. Ryvu has established partnerships with global companies including Merck, Menarini, Galapagos, Exelixis, and BioNTech. Founded in 2007 and headquartered in Kraków, Lesser Poland, the company is listed on the Warsaw Stock Exchange as part of the sWIG80 index; in 2025 it formed a strategic collaboration with BioNTech US Inc. to support trial site activation and patient recruitment for BioNTech's oncology therapies in Poland.

Find Ryvu Therapeutics employees' phone numbers or email addresses

Ryvu Therapeutics Global Highlights

Location
Employees

Europe
219

Minus sign iconPlus sign icon
  • Poland
    208
  • Germany
    2
  • United Kingdom Of Great Britain And Northern Ireland
    2
  • France
    2
  • Italy
    1
  • Ukraine
    1
  • Portugal
    1
  • Serbia
    1
  • Switzerland
    1

North America
4

Minus sign iconPlus sign icon
  • United States Of America
    4

Asia
1

Minus sign iconPlus sign icon
  • Lebanon
    1

Ryvu Therapeutics's Leadership

  • Chief Executive Officer, Co-Founder at Ryvu Therapeutics
    P. P.
    Chief Executive Officer, Co-Founder
  • Chief Scientific Officer, Executive Vice President at Ryvu Therapeutics
    K. B.
    Chief Scientific Officer, Executive Vice President
  • Chief People Officer, Management Board Member at Ryvu Therapeutics
    J. Ż.
    Chief People Officer, Management Board Member
  • Chief Medical Officer at Ryvu Therapeutics
    H. N.
    Chief Medical Officer
  • Chief Operating Officer, Management Board Member at Ryvu Therapeutics
    K. S.
    Chief Operating Officer, Management Board Member
  • Head Of Procurement | Clinical Development, Research & Discovery at Ryvu Therapeutics
    M. D. -. A.
    Head Of Procurement | Clinical Development, Research & Discovery
  • Head Of Translational Medicine At Ryvu Therapeutics at Ryvu Therapeutics
    T. R.
    Head Of Translational Medicine At Ryvu Therapeutics
  • Head Of Translational Medicine at Ryvu Therapeutics
    M. M.
    Head Of Translational Medicine

Ryvu Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Biotechnology
  • Program & Project Management
  • Purchasing
  • Entrepreneurship
  • Human Resources
  • Other
  • Business

Contact profiles from Ryvu Therapeutics

Name
Title
Contact
Location
Last Update
  • Chief Executive Officer, Co-Founder at Ryvu Therapeutics
    P. P.
    Chief Executive Officer, Co-Founder
    Oct 05, 2026
  • Chief Scientific Officer, Executive Vice President at Ryvu Therapeutics
    K. B.
    Chief Scientific Officer, Executive Vice President
    Aug 13, 2026
  • Chief People Officer, Management Board Member at Ryvu Therapeutics
    J. Ż.
    Chief People Officer, Management Board Member
    Oct 17, 2026
  • Chief Medical Officer at Ryvu Therapeutics
    H. N.
    Chief Medical Officer
    Switzerland, Basel-City
    Sep 04, 2026
  • Chief Operating Officer, Management Board Member at Ryvu Therapeutics
    K. S.
    Chief Operating Officer, Management Board Member
    Poland, Lesser Poland
    Oct 14, 2026
  • Head Of Procurement | Clinical Development, Research & Discovery at Ryvu Therapeutics
    M. D. -. A.
    Head Of Procurement | Clinical Development, Research & Discovery
    France, Île-de-France
    Sep 17, 2026
  • Head Of Translational Medicine At Ryvu Therapeutics at Ryvu Therapeutics
    T. R.
    Head Of Translational Medicine At Ryvu Therapeutics
    Italy, Lombardy
    Oct 02, 2026
  • Head Of Translational Medicine at Ryvu Therapeutics
    M. M.
    Head Of Translational Medicine
    Apr 14, 2026
  • Head Of Translational Immuno-Oncology Research at Ryvu Therapeutics
    S. C.
    Head Of Translational Immuno-Oncology Research
    Jun 29, 2026
  • Head Of In Vivo Research Department at Ryvu Therapeutics
    A. M.
    Head Of In Vivo Research Department
    Poland
    Jul 30, 2025

Frequently Asked Questions

What is Ryvu Therapeutics known for?

Minus sign iconPlus sign icon
Ryvu Therapeutics was founded in 2007 and operates in the Biotechnology Research industry. Explore Ryvu Therapeutics's company overview page for more information.

What is Ryvu Therapeutics's most common email format?

Minus sign iconPlus sign icon
Ryvu Therapeutics employees' email format typically follows the pattern of First.Last@ryvu.com. Trying to find reliable and up-to-date employee contact data? Find more Ryvu Therapeutics email formats with LeadIQ.

How many employees does Ryvu Therapeutics have currently?

Minus sign iconPlus sign icon
Ryvu Therapeutics has approximately 213 employees as of October 2026. These team members are located across 3 continents, including Europe, North America and Asia.

Who are Ryvu Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of October 2026, Ryvu Therapeutics's key employees include:

  • Chief Executive Officer, Co-Founder: P. P.
  • Chief Scientific Officer, Executive Vice President: K. B.
  • Chief People Officer, Management Board Member: J. Ż.
  • Chief Medical Officer: H. N.
  • Chief Operating Officer, Management Board Member: K. S.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.